> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Supernus Will Report Third Quarter Results After The Close On October 29
- URL: https://www.bullished.co/supernus-will-report-third-quarter-results-after-the-close-on-october-29-31f25e2c/
- Published: 2026-10-19T21:21:17.000Z
- Updated: 2026-10-23T12:52:21.000Z
- Description: The drugmaker will hold a 4:30 p.m. ET call with its CEO and CFO, and a webcast replay will stay up for 60 days.
- Author: Matteo Parrino
- Tags: Earnings, SUPN, Industry: Healthcare

[Supernus Pharmaceuticals](https://www.bullished.co/tag/supn/) will report its [third quarter 2026 results](https://www.sec.gov/Archives/edgar/data/0001356576/000135657626000043/supn-20261019.htm?ref=bullished.co) after the market closes on Thursday, October 29, according to an 8-K the company filed Monday. Management will discuss the numbers on a live call and webcast at 4:30 p.m. ET that day.

## What the 8-K says

The filing, made under Item 2.02 (the item for results of operations), carries a press release as an exhibit. The [press release](https://www.sec.gov/Archives/edgar/data/0001356576/000135657626000043/ex-99110x19xearningscallan.htm?ref=bullished.co) is dated Monday and announces the reporting date and the call. It contains no results.

President and CEO Jack Khattar and Senior Vice President and CFO Tim Dec will host the call. After their prepared remarks and a discussion of business results, the call will be open for questions.

The company describes itself as a biopharmaceutical company focused on treatments for central nervous system diseases. Its listed approved treatments cover ADHD, dyskinesia in Parkinson's disease patients receiving levodopa-based therapy, hypomobility in Parkinson's, postpartum depression, epilepsy, migraine, cervical dystonia and chronic sialorrhea.

## How to listen

The live webcast will sit in the Events & Presentations section of the company's investor relations website. Participants can pre-register before the call and will then receive a dial-in number with a personalized conference code.

The company asks callers to dial in 15 minutes before the start time. A replay will be posted on the investor site, and the webcast will stay on the company's website for 60 days after the live call.

## The stock going in

Supernus shares closed Monday at $39.84, up 5.17% from the prior session's $37.88\. That move came before the 4:51 p.m. ET filing, so it is not a reaction to the announcement.

The next date that matters is Thursday, October 29: results after the close, then the call at 4:30 p.m. ET.

### Sources

- [8-K Filing — SUPERNUS PHARMACEUTICALS, INC. (SUPN)](https://www.sec.gov/Archives/edgar/data/0001356576/000135657626000043/supn-20261019.htm?ref=bullished.co) — SEC EDGAR
- [Exhibit ex-99110x19xearningscallan.htm — SUPERNUS PHARMACEUTICALS, INC. 8-K exhibit](https://www.sec.gov/Archives/edgar/data/0001356576/000135657626000043/ex-99110x19xearningscallan.htm?ref=bullished.co) — SEC EDGAR

### More on Supernus Pharmaceuticals

- [Supernus Says FDA Recognized 7 Years Of Orphan Exclusivity For Parkinson's Drug Onapgo](https://www.bullished.co/supernus-says-fda-recognized-7-years-of-orphan-exclusivity-for-parkinsons-drug-onapgo-0ecd5919/)
- [Supernus Holders Back Indivior Merger With 48.2 Million Votes For, 235,601 Against](https://www.bullished.co/supernus-holders-back-indivior-merger-with-48-2-million-votes-for-235-601-against-51828290/)
- [Supernus Publishes Cantor's Merger Math: $50.55 To $59.50 A Share, And A Denial Any Of It Was Required](https://www.bullished.co/supernus-publishes-cantors-merger-math-50-55-to-59-50-a-share-and-a-denial-any-of-it-was-5fdaa8bc/)

[All Supernus Pharmaceuticals (SUPN) coverage →](https://www.bullished.co/tag/supn/)